In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate

Michael Rice Biography and Net Worth

CEO of BioLife Solutions

Michael Rice is the CEO of BioLife Solutions, a leading supplier of class-defining cell and gene therapy bioproduction tools and services.

Rice joined the company in 2006 as president, CEO and director, and he served as chairman of the board from 2007 to 2013. In his last five years with the company, Rice has driven annual revenue growth to greater than 30 percent. During his tenure, BioLife has twice been named one of Seattle Business Magazine’s 100 Best Companies to Work For.

Prior to BioLife, Rice spent two years as the senior business development manager of medical and wireless products for AMI Semiconductor Inc. His career includes 30 years of experience in leadership and entrepreneurial roles in the medical and high-tech industries, including a four-year stint at Cardiac Science where he worked as the director of business development and marketing. From 1998 to 2000, Rice served as VP of sales and marketing for TEGRIS Corporation, a privately-held network services provider.

Early in his career, Rice held a series of marketing and sales management roles at Physio Control Corporation before it was acquired by Medtronic. He currently serves on the board of Sexton Biotechnologies, and he was formerly a board member for Savsu Technologies from 2014 to 2019.

Rice earned his B.S. in business administration from City University of Seattle.

What is Michael Rice's net worth?: The estimated net worth of Michael Rice is at least $8.68 million as of October 30th, 2023. Mr. Rice owns 347,085 shares of BioLife Solutions stock worth more than $8,680,596 as of November 21st. This net worth estimate does not reflect any other investments that Mr. Rice may own. Learn More about Michael Rice's net worth.
How do I contact Michael Rice?: The corporate mailing address for Mr. Rice and other BioLife Solutions executives is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. BioLife Solutions can also be reached via phone at (425) 402-1400 and via email at [email protected]. Learn More on Michael Rice's contact information.
Has Michael Rice been buying or selling shares of BioLife Solutions?: Michael Rice has not been actively trading shares of BioLife Solutions during the last ninety days. Most recently, Michael Rice sold 72,603 shares of the business's stock in a transaction on Monday, October 30th. The shares were sold at an average price of $9.13, for a transaction totalling $662,865.39. Following the completion of the sale, the chief executive officer now directly owns 347,085 shares of the company's stock, valued at $3,168,886.05. Learn More on Michael Rice's trading history.
Who are BioLife Solutions' active insiders?: BioLife Solutions' insider roster includes Sarah Aebersold (VP), Todd Berard (CMO), Roderick de Greef (CFO), Karen Foster (Insider), Andrew Hinson (Director), Aby Mathew (VP), Michael Rice (CEO), Joseph Schick (Director), Marcus Schulz (CRO), and Troy Wichterman (CFO). Learn More on BioLife Solutions' active insiders.
Are insiders buying or selling shares of BioLife Solutions?: In the last twelve months, insiders at the medical equipment provider sold shares 75 times. They sold a total of 136,717 shares worth more than $2,703,077.70. The most recent insider tranaction occured on November, 18th when EVP Aby J Mathew sold 17,604 shares worth more than $352,960.20. Insiders at BioLife Solutions own 2.2% of the company. Learn More about insider trades at BioLife Solutions.
Information on this page was last updated on 11/18/2024.

Michael Rice Insider Trading History at BioLife Solutions

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/30/2023	Sell	72,603	$9.13	$662,865.39	347,085
9/28/2023	Sell	831	$14.16	$11,766.96	418,635
8/25/2023	Sell	1,729	$10.99	$19,001.71	416,906
8/14/2023	Sell	277	$12.38	$3,429.26	418,635
6/27/2023	Sell	877	$22.91	$20,092.07	418,912
5/31/2023	Sell	1,679	$23.21	$38,969.59	419,789
5/17/2023	Sell	33,333	$21.04	$701,326.32	421,468
5/15/2023	Sell	190	$18.71	$3,554.90	454,801
4/6/2023	Sell	3,214	$20.03	$64,376.42	447,480
3/29/2023	Sell	936	$20.62	$19,300.32	450,694
3/7/2023	Sell	549	$22.95	$12,599.55	451,630
3/1/2023	Sell	4,290	$22.75	$97,597.50	452,179
2/9/2023	Sell	144	$24.60	$3,542.40	456,469
12/28/2022	Sell	898	$16.90	$15,176.20	357,575
11/29/2022	Sell	931	$19.93	$18,554.83	358,473
11/10/2022	Sell	164	$23.16	$3,798.24	362,154
9/29/2022	Sell	830	$23.02	$19,106.60	362,318
8/10/2022	Sell	171	$23.17	$3,962.07	363,550
6/28/2022	Sell	889	$14.86	$13,210.54	361,452
5/27/2022	Sell	749	$14.53	$10,882.97	360,541
5/13/2022	Sell	165	$12.32	$2,032.80	360,326
4/18/2022	Sell	24,400	$17.59	$429,196.00	360,491
4/13/2022	Sell	10,000	$19.06	$190,600.00	384,891
4/11/2022	Sell	10,000	$19.55	$195,500.00	327,155
3/29/2022	Sell	830	$22.24	$18,459.20
3/9/2022	Sell	10,000	$23.81	$238,100.00
3/7/2022	Sell	10,000	$23.80	$238,000.00
3/1/2022	Sell	874	$23.78	$20,783.72
2/10/2022	Sell	690	$29.38	$20,272.20
2/3/2022	Sell	16,670	$27.84	$464,092.80
2/1/2022	Sell	16,666	$29.90	$498,313.40
1/12/2022	Sell	16,666	$31.72	$528,645.52
1/10/2022	Sell	16,666	$30.83	$513,812.78
12/29/2021	Sell	928	$39.37	$36,535.36
12/15/2021	Sell	16,666	$32.80	$546,644.80
12/13/2021	Sell	16,666	$33.82	$563,644.12
12/9/2021	Sell	11,464	$35.15	$402,959.60
12/7/2021	Sell	11,461	$36.52	$418,555.72
11/4/2021	Sell	11,461	$56.81	$651,099.41
11/2/2021	Sell	11,461	$54.72	$627,145.92
10/14/2021	Sell	3,215	$39.97	$128,503.55
10/7/2021	Sell	11,461	$40.55	$464,743.55
10/5/2021	Sell	11,461	$40.63	$465,660.43
9/28/2021	Sell	907	$43.12	$39,109.84
9/9/2021	Sell	11,461	$52.59	$602,733.99	276,923
9/7/2021	Sell	11,461	$52.50	$601,702.50
8/26/2021	Sell	848	$57.26	$48,556.48	265,462
8/5/2021	Sell	11,461	$48.37	$554,368.57
8/3/2021	Sell	11,461	$48.26	$553,107.86	277,771
7/8/2021	Sell	11,464	$46.15	$529,063.60	280,771
7/6/2021	Sell	11,461	$46.28	$530,415.08	280,771
6/10/2021	Sell	11,461	$36.47	$417,982.67	281,673
6/8/2021	Sell	11,461	$35.54	$407,323.94	281,673
5/28/2021	Sell	802	$33.87	$27,163.74	270,212
5/6/2021	Sell	11,461	$30.41	$348,529.01	282,475
5/4/2021	Sell	11,461	$30.15	$345,549.15	282,475
4/8/2021	Sell	11,461	$35.32	$404,802.52	273,988
4/1/2021	Sell	10,149	$36.53	$370,742.97	272,676
3/26/2021	Sell	3,809	$35.01	$133,353.09	246,522
2/26/2021	Sell	861	$39.57	$34,069.77	250,331
2/19/2021	Sell	10,107	$40.76	$411,961.32	210,354
2/17/2021	Sell	9,917	$41.55	$412,051.35	210,354
12/1/2020	Sell	813	$35.49	$28,853.37	202,843
11/16/2020	Sell	34,383	$31.80	$1,093,379.40	215,117
11/12/2020	Sell	11,461	$32.38	$371,107.18	215,117
10/8/2020	Sell	18,750	$28.55	$535,312.50	222,406
10/6/2020	Sell	18,750	$29.54	$553,875.00	222,406
9/29/2020	Sell	4,690	$28.63	$134,274.70	203,656
9/10/2020	Sell	18,750	$23.24	$435,750.00	227,096
9/8/2020	Sell	18,750	$21.64	$405,750.00	227,096
8/26/2020	Sell	877	$20.48	$17,960.96	208,346
8/13/2020	Sell	18,750	$18.64	$349,500.00	227,973
8/11/2020	Sell	18,750	$19.91	$373,312.50	227,973
7/16/2020	Sell	18,750	$19.30	$361,875.00	232,973
7/14/2020	Sell	18,750	$18.67	$350,062.50	232,973
6/19/2020	Sell	18,750	$16.37	$306,937.50	232,973
6/11/2020	Sell	18,750	$15.01	$281,437.50	232,973
5/28/2020	Sell	516	$16.87	$8,704.92	214,223
5/15/2020	Sell	18,750	$14.23	$266,812.50	233,489
5/13/2020	Sell	18,750	$15.45	$289,687.50	233,489
4/15/2020	Sell	18,750	$9.66	$181,125.00	233,489
4/13/2020	Sell	18,750	$9.03	$169,312.50	233,489
3/12/2020	Sell	18,750	$8.44	$158,250.00	184,574
3/10/2020	Sell	18,750	$12.16	$228,000.00	184,574
2/26/2020	Sell	2,190	$15.02	$32,893.80	165,824
2/13/2020	Sell	18,750	$14.17	$265,687.50	186,764
2/11/2020	Sell	18,750	$13.69	$256,687.50	186,764
12/12/2019	Sell	10,247	$15.11	$154,832.17	168,014
12/10/2019	Sell	10,000	$15.37	$153,700.00	168,014
11/14/2019	Sell	10,000	$13.98	$139,800.00	185,014
11/12/2019	Sell	10,000	$16.78	$167,800.00	185,014
10/17/2019	Sell	10,000	$16.26	$162,600.00	185,014
10/15/2019	Sell	10,000	$15.93	$159,300.00	185,014
9/11/2019	Sell	14,571	$19.36	$282,094.56	189,014
9/9/2019	Sell	14,000	$19.43	$272,020.00	189,014
8/15/2019	Sell	9,905	$18.07	$178,983.35	184,919
8/13/2019	Sell	9,000	$17.07	$153,630.00	184,014
7/18/2019	Sell	18,903	$16.29	$307,929.87	184,014
7/16/2019	Sell	9,000	$16.29	$146,610.00	184,014
6/13/2019	Sell	18,903	$17.37	$328,345.11	184,014
6/11/2019	Sell	9,000	$17.64	$158,760.00	184,014
5/15/2019	Sell	7,088	$16.94	$120,070.72	182,102
4/10/2019	Sell	7,088	$17.91	$126,946.08	182,102
3/13/2019	Sell	7,088	$17.19	$121,842.72	182,102
2/13/2019	Sell	7,088	$16.03	$113,620.64	146,605
1/15/2019	Sell	14,781	$12.14	$179,441.34	154,298
12/13/2018	Sell	14,781	$11.44	$169,094.64	154,298
10/1/2018	Sell	12,540	$17.57	$220,327.80	152,057
9/5/2018	Sell	12,540	$21.55	$270,237.00	152,057
8/16/2018	Sell	12,540	$19.50	$244,530.00	152,057
7/16/2018	Sell	12,540	$19.90	$249,546.00	152,057
6/18/2018	Sell	12,540	$12.89	$161,640.60	152,057
5/15/2018	Sell	12,540	$8.65	$108,471.00	152,057
4/17/2018	Sell	12,540	$7.18	$90,037.20	146,157
3/15/2018	Sell	12,540	$5.27	$66,085.80
2/15/2018	Sell	12,540	$5.26	$65,960.40	152,057
1/16/2018	Sell	12,540	$5.57	$69,847.80	152,057
5/14/2014	Buy	8,000	$2.56	$20,480.00
5/13/2014	Buy	12,767	$2.26	$28,853.42

Michael Rice Buying and Selling Activity at BioLife Solutions

BioLife Solutions Company Overview

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Today's Range

Now: $25.01

$21.90

$25.11

50 Day Range

MA: $23.96

$20.47

$26.60

2 Week Range

Now: $25.01

$11.91

$28.88

Volume

926,418 shs

Average Volume

385,125 shs

Market Capitalization

$1.16 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.88

Bill Gates’s Next Big AI Bet: Stargate

From Brownstone Research | Ad